For laboratory & research use only — not for human consumption.
REGENIX
MetabolicAdvanced

Metabolic & Recomposition Track

Goal — Metabolic and body-composition research

A structured research framework built around triple-agonist incretin signaling, organized into titration, plateau, and maintenance phases.

Components

Retatrutide

Product →

Primary incretin research compound (GLP-1/GIP/glucagon).

Bacteriostatic Water

Product →

Reconstitution.

Phases

  1. 1

    Phase 1 — Titration

    Low-and-slow introduction while researchers characterize tolerance markers in their model.

  2. 2

    Phase 2 — Plateau

    Stable observation window for tracking primary metabolic endpoints.

  3. 3

    Phase 3 — Maintenance

    Step-down framework used to study durability of observed changes.

Research notes

  • Incretin research compounds are typically studied with careful titration to characterize tolerability.
  • Endpoints and timelines are defined by the researcher's own validated protocol.
All products are sold for laboratory and research use only. Not for human consumption, diagnosis, treatment, or cure of any condition. Not evaluated by the FDA. This material is educational and does not constitute medical advice or dosing guidance.